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Editorial: Hormones and sexual behaviour that it is the level of free unbound hormone rather than the total hormone in the circulation that is important, but also that hormonal mechanisms may not be usefully reflected in the circulating levels.
While there are strong clinical impressions of the importance of androgens in restoring sexual function to men with post-pubertal primary hypogonadism, evidence of a systematic and detailed kind is hard to find. The variable response of men to castration (Bremer, 1959) indicates that the relationship is complex and the extent to which androgens are necessary or sufficient for male sexual responsiveness remains obscure.
When we turn to the human female, the evidence is even more sparse, with a more or less total absence of endocrine data from sexually dysfunctional women. The cyclical nature of the female endocrine system, and the relatively low levels of circulating testosterone have increased methodological difficulties. But considering the vast number of women receiving steroidal contraceptives or post-menopausal hormone replacement therapy, this lack of evidence is remarkable, and in large part results from reluctant or inadequate behavioural assessment. Our most relevant data are from sub-human primates. Androgens are necessary for the normal sexual responsiveness (i.e. proceptivity and receptivity) of the female monkey (Everitt & Herbert, 1971) , whereas the attractiveness of the female to the male is oestrogen dependent. Oestrogens may also be necessary (though not sufficient) for female proceptivity (i.e. sexual approach behaviour by the female) (Baum et al. 1977) .
The enhancing effect of androgens on human female sexual responsiveness has been described many times at an anecdotal level. No systematic or controlled evidence on this point has been published, although a study has recently been completed demonstrating such effectiveness of testosterone when combined with counselling (M. A. Carney, J. Bancroft & A. M. Mathews -unpublished data) .
The present state of our knowledge on the effects of steroidal contraceptives on female sexuality can best be described as confused. There is strong clinical evidence of an association between oral contraceptive use and sexual impairment (Royal College of General Practitioners, 1974), but psychological reactions are difficult to distinguish from the pharmacological effects of the steroids (AznarRamos et al. 1969) , and 'the pill' may often be used as the scapegoat when this problem has other determinants. The two best controlled studies have shown that the distribution of coitus during the 28-day cycle may be altered without the overall frequency being affected (Udry et al. 1973) , and that sexual side-effects are infrequent and probably secondary to mood changes when they do occur (Cullberg, 1973) . While methodological problems in this area are formidable, there is an obvious need to relate behavioural change to hormonal change. Evidence of androgen levels in pill-takers shows a variable picture (Apostolakis et al. 1966; Kjeld et al. 1976 ) and there may be important differences between the various progestogens in their effects on androgen levels, because of differential effects on androgen binding (Victor et al. 1976) .
The effects of hormone replacement therapy on the sexual behaviour of post-menopausal women awaits proper evaluation, but one of the most convincing effects is likely to be the restoration of normal vaginal responsiveness by systematic or local oestrogens.
The current situation with the female is, therefore, even more uncertain and complex than in the male. Androgens are likely to be important, oestrogens have a probable peripheral role, but a very uncertain central role, and the relevance of progestogens is less clear than it seemed to be some years ago. With the growing necessity to evaluate properly steroidal contraceptives and hormonal replacement therapy and with improvements in both behavioural and hormonal assessment, we can hope for greater clarification in the near future.
Two other aspects of sexuality to be considered are gender identity and sexual preferences. In the first case, evidence has been well collected by Money & Ehrhardt (1972) . While there is strong evidence for the role of pre-natal androgens in determining masculine gender identity, it remains difficult to distinguish between social learning shaped by anatomical features (e.g. masculinization of external genitalia) and the direct effect of hormones on psychological development. Part of the problem stems from the reliance on the various types of early onset endocrine anomaly such as the adreno-genital syndrome or androgen insensitivity syndrome. One of the most promising lines for future research stems from the finding that normal male infants show marked rises in circulating testosterone betweenbetween these early androgen levels and later psychological development therefore becomes a possibility.
Hirschfeld in the 1920s suggested that homosexual preferences resulted from hormonal 'intersex states'. Although early endocrine studies failed to support this idea, interest has been renewed recently with a spate of studies comparing the hormonal status of homosexual and heterosexual males (e.g. Loraine et al. 1970; Kolodny et al. 1971; Doerr et al. 1973; Brodie et al. 1974 ; for a fuller review, see Bancroft, 1977) . The varied and conflicting results have more or less cancelled each other out, and have revealed methodological naiveties reminiscent of early biochemical studies of schizophrenia. Two studies both reported an abnormal ratio of androsterone to etiocholanolone in the urine (both breakdown products of testosterone) but the relevance of such a finding remains obscure (Margolese & Janiger, 1973; Evans, 1972) . The most sophisticated approach has been the search for the typically female positive feedback response of the hypothalamus to oestrogen provocation, as a possible indicator of incomplete masculinization of the male homosexual's brain. Dorner et al. (1975) have claimed such a difference between homosexual and heterosexual males, though the effect was not great. This requires replication, but in any case, the relevance of this positive feedback response to sexual differentiation of the primate and human brain is still unclear.
In spite of major technological advances, therefore, our understanding of the relationship between hormones and human sexual behaviour has moved forward very little. What is happening is a greater definition of the relevant questions and awareness of the methodological complexities in answering them. The next phase of research should, therefore, see more real progress, but the relationships so clarified are likely to be highly complex. Those psychiatrists looking for simple biological explanations of human behaviour would be advised to search elsewhere.
JOHN BANCROFT
